Product Development Global Cardiac Arrhythmia Monitoring Devices Market

The global cardiac arrhythmia monitoring devices market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period (2023-2031). The increasing incidence & prevalence of cardiac arrhythmia along with the development of advanced products and technology for the better monitoring of this disorder is a key factor driving the growth of the global market. For instance, in October 2023, InfoBionic received FDA 510(k) clearance for its next-generation remote ECG monitoring device with a Bluetooth diagnostic six-lead sensor for patients who require cardiac monitoring. The Bluetooth-enabled device requires no patient intervention and can communicate with physicians via cellular networks. MoMe ARC is a solution that includes a 4-in-1 Gateway device that seamlessly transitions between 2-day in addition to Extended Holter tests, Event, and MCT modes remotely, streamlining patient monitoring time and minimizing delays. In addition, MoMe ARC leverages a comprehensive cloud-based proprietary platform to deliver on-demand, actionable data and analytics directly to the clinicians.

Browse the full report description of “Cardiac Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report by Device Type (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, and Holter Monitoring Devices), and by Service Provider (Mobile Cardiac Telemetry Monitoring Service Providers, Independent Diagnostic Testing Facilities/Clinics) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/cardiac-arrhythmia-monitoring-devices-market

Additionally, in June 2023, BIOTRONIK announced the implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). This first implant marks the next step in the advancement of cardiac monitoring technology. BIOMONITOR IV is a state-of-the-art ICM that pairs BIOTRONIK's SmartECG technology with AI* to reduce all false positive detections by 86.0% while preserving 98.0% of true episodes. It is also the only ICM capable of distinguishing between premature atrial contractions (PACs) and premature ventricular contractions (PVCs) to provide healthcare professionals with better tools for risk stratification and diagnosis.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Device Type

o By Service Provider

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- includes Abbott Laboratories, Medtronic PLC, ACSDiangostics, GE Healthcare, and Koninklijke Philips NV among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cardiac Arrhythmia Monitoring Devices Market Report Segment

By Device Type

• Event Monitoring Devices
• Continuous Rhythm Monitoring Devices
• Holter Monitoring Devices

By Service Provider 

• Mobile Cardiac Telemetry Monitoring Service Providers
• Independent Diagnostic Testing Facilities/Clinics

Global Cardiac Arrhythmia Monitoring Devices Market Report Segment by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cardiac-arrhythmia-monitoring-devices-market